First pilot study for newborn screening of severe T and B lymphopenias in Colombia

Sebastián Gutiérrez-Hincapié1, Carlos Muskus-López2, Isaura Pilar Sánchez3

  • 1Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Insights

This pilot study explored neonatal screening for congenital lymphopenias using T-cell and B-cell receptor excision circles (TREC and KREC). Results showed normal levels in newborns, suggesting the method

Area of Science:

  • Immunology
  • Neonatal Screening
  • Genetics

Context:

  • Congenital lymphopenias increase infection susceptibility in newborns.
  • Early detection is crucial for timely treatment and preventing severe outcomes.
  • Colombia lacks established newborn screening for these conditions.

Purpose:

  • To pilot neonatal screening for congenital lymphopenias in Medellín, Colombia.
  • To quantify T-cell receptor excision circles (TRECs) and B-cell receptor excision circles (KRECs) in newborn blood samples.
  • To establish preliminary cut-off values for TREC and KREC for future screening programs.

Summary:

  • Quantified TRECs and KRECs in 1,092 newborns and 6 patients using dried blood spots and qPCR.
  • Patients with suspected lymphopenia had undetectable or very low TREC levels.
  • Normal TREC and KREC levels were observed in screened newborns; correlations with birth weight and prematurity were noted.

Impact:

  • Presents the first preliminary study for early lymphopenia detection in Colombia.
  • Proposes TREC and KREC cut-off values (119 and 69 copies/μl, respectively) for national newborn screening.
  • Aims to improve early diagnosis, treatment, and outcomes for infants with congenital lymphopenias.
Abstract

Related Concept Videos